Impact Of Decreasing Copayments On Medication Adherence Within A Disease Management Environment
Top Cited Papers
- 1 January 2008
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 27 (1) , 103-112
- https://doi.org/10.1377/hlthaff.27.1.103
Abstract
This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.Keywords
This publication has 6 references indexed in Scilit:
- Prescription Drug Cost SharingJAMA, 2007
- Value-Based Insurance DesignHealth Affairs, 2007
- Physician Practice Size And Variations In Treatments And Outcomes: Evidence From Medicare Patients With AMIHealth Affairs, 2007
- Methods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiology and Drug Safety, 2006
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- Population-Based Disease Management Under Fee-For-Service MedicareHealth Affairs, 2003